Bronchodil tablets are used to treat respiratory conditions associated with thick, sticky mucus. They help thin the mucus and make it easier to cough up. Order online.
Each tablet contains:
Active ingredient: Ambroxol hydrochloride — 30 mg.
Excipients: Lactose, microcrystalline cellulose, corn starch, magnesium stearate, anhydrous colloidal silicon dioxide, povidone 30, talc.
Bronchodil tablets are used to treat respiratory tract conditions associated with thick, sticky mucus and difficulty expectorating sputum.
The product is indicated for:
Acute and chronic bronchitis;
Pneumonia;
Bronchial asthma;
Bronchiectasis.
Absolute contraindications:
Hypersensitivity to ambroxol or any other component of the product;
Gastric or duodenal ulcer disease;
Epileptic syndrome;
Children under 2 years of age. Another formulation, Bronchodil syrup, is available for children in this age group.
Relative contraindications and precautions:
Bronchodil should be used with particular caution in patients with impaired renal function or severe liver disease. Dose reduction and longer intervals between doses may be necessary. Treatment should be carried out under medical supervision.
Special caution is also required in patients with impaired bronchial motility and excessive secretion production.
Although there is no reliable evidence of adverse effects of ambroxol on the fetus or infant, the product should be used during pregnancy, particularly in the first trimester, and during breastfeeding only after assessing the potential benefits and risks and following a doctor's advice.
Take the tablets after meals with a sufficient amount of warm liquid, such as water, juice, or tea.
Adults and children over 12 years of age:
During the first 2–3 days: 1 tablet 3 times daily (90 mg per day).
Thereafter: 1 tablet twice daily (60 mg per day).
Children aged 6–12 years:
During the first 2 days: ½ tablet 2–3 times daily (30–45 mg per day).
Thereafter: ½ tablet twice daily (30 mg per day).
The duration of treatment depends on the course of the disease. Use for longer than 4–5 days without medical advice is not recommended.
Possible adverse effects include:
Weakness and headache;
Dryness of the mouth and respiratory tract;
Increased salivation;
Rhinorrhea (nasal discharge);
Stomach pain;
Nausea and vomiting;
Diarrhea or constipation;
Dysuria (difficulty or discomfort during urination);
Exanthema (skin rash).
If any adverse effect occurs, including one not listed above, consult a doctor or pharmacist.
Concomitant use with cough suppressants, such as codeine-containing medicines, is not recommended because suppressing the cough may make it more difficult to clear mucus from the respiratory tract.
Concomitant use with antibiotics, including amoxicillin, cefuroxime, erythromycin, and doxycycline, may improve antibiotic penetration into the respiratory tract.
Ambroxol has a high tolerance profile, including at doses of up to 25 mg/kg. However, overdose may cause:
Increased salivation;
Nausea;
Vomiting;
Decreased blood pressure.
Seek immediate medical attention in the event of an overdose. Treatment depends on the patient's condition and may include monitoring of hemodynamic parameters and symptomatic management.
Blister pack containing 10 tablets. Two blisters are supplied in a cardboard box together with the package leaflet.
Store in a dry place, protected from light, at a temperature not exceeding 25°C. Keep out of the reach of children.
Shelf life: 3 years. Do not use after the expiry date.
